Medication – Don't Forget To Breathe

Effectiveness of Fluticasone Furoate–Vilanterol for COPD in Clinical Practice

Guidelines on the management of chronic obstructive pulmonary disease (COPD) are based on numerous randomized, controlled trials of efficacy, which are usually generated for registration purposes. However, these trials have included patients who were selected with the use of strict criteria and were closely monitored, and therefore the results have limited relevance to everyday clinicalContinue reading “Effectiveness of Fluticasone Furoate–Vilanterol for COPD in Clinical Practice”

Novel Drug Has Dual Action in Asthma, COPD

A novel inhaled drug appeared safe as a dual bronchodilator and anti-inflammatory in asthma and chronic obstructive pulmonary disease (COPD), a series of proof-of-concept studies showed. In COPD patients, nebulized RPL554 boosted forced expiratory volume in 1 second (FEV1) by 17% versus placebo, with peak effects comparable to inhaled beta-2 agonists, Clive P. Page, PhD,Continue reading “Novel Drug Has Dual Action in Asthma, COPD”